Lilly to invest US$ 3 bn in China to boost supply of new obesity drug; Servier acquires Day One Biopharma for US$ 2.5 bn
In Phispers this week, Eli Lilly announced its plans to invest US$
3 billion in China over the next decade in order to build p...
Impressions : 2555
US exits WHO; Moderna to stop investing in new late-stage vaccine trials due to increased opposition to immunizations
Public health suffered several setbacks over the last week. First,
the United States formally exited the World Health Organiza...
Impressions : 1995
Pfizer seals up to US$ 10 bn deal for Metsera; FDA lifts black box warning on hormone therapies for menopause
In Phispers this week, Pfizer won its high stakes battle with Novo
Nordisk for the obesity-focused biotech Metsera. The deal i...
Impressions : 1485
Lilly’s Zepbound becomes first FDA-approved therapy for sleep apnea; Novo wins nod for daily hemophilia shot
This week’s Phispers is a double bill with news from the last two weeks. Through much of December, the US Food and Drug A...
Impressions : 1461
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.